228 related articles for article (PubMed ID: 35277390)
1. Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.
Lu J; He Y; Terkeltaub R; Sun M; Ran Z; Xu X; Wang C; Li X; Hu S; Xue X; Yan F; Zhang H; Yin H; Shi Y; Dalbeth N; Li C
Ann Rheum Dis; 2022 Aug; 81(8):1189-1193. PubMed ID: 35277390
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
[TBL] [Abstract][Full Text] [Related]
3. Risk of gout flares after COVID-19 vaccination: A case-crossover study.
Li H; Dalbeth N; Wallace ZS; Sparks JA; Li X; Zeng C; Wang Y; Xie D; Lei G; Wei J; Zhang Y
Semin Arthritis Rheum; 2022 Oct; 56():152059. PubMed ID: 35797765
[TBL] [Abstract][Full Text] [Related]
4. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial.
Stamp L; Horne A; Mihov B; Drake J; Haslett J; Chapman PT; Frampton C; Dalbeth N
Ann Rheum Dis; 2023 Dec; 82(12):1626-1634. PubMed ID: 37652661
[TBL] [Abstract][Full Text] [Related]
5. Risk of gout flares after vaccination: a prospective case cross-over study.
Yokose C; McCormick N; Chen C; Neogi T; Chaisson C; Terkeltaub R; Hunter DJ; Zhang Y; Choi H
Ann Rheum Dis; 2019 Nov; 78(11):1601-1604. PubMed ID: 31366470
[TBL] [Abstract][Full Text] [Related]
6. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
[TBL] [Abstract][Full Text] [Related]
7. Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.
Pascart T; Norberciak L; Ea HK; Graf S; Guggenbuhl P; Lioté F
Rheumatology (Oxford); 2019 Dec; 58(12):2181-2187. PubMed ID: 31177284
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
Rheumatology (Oxford); 2021 Dec; 61(1):223-229. PubMed ID: 33764413
[TBL] [Abstract][Full Text] [Related]
9. Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.
Mandell BF; Fields TR; Edwards NL; Yeo AE; Lipsky PE
Clin Exp Rheumatol; 2021; 39(5):1085-1092. PubMed ID: 33427618
[TBL] [Abstract][Full Text] [Related]
10. Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.
Parperis K
Ann Rheum Dis; 2021 Dec; 80(12):e202. PubMed ID: 31776116
[No Abstract] [Full Text] [Related]
11. One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.
Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Perez-Ruiz F; Hammer HB
Arthritis Res Ther; 2022 Apr; 24(1):88. PubMed ID: 35443675
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of acute flares when initiating febuxostat for chronic gouty arthritis in a real-world clinical setting.
Yu J; Qiu Q; Liang L; Yang X; Xu H
Mod Rheumatol; 2018 Mar; 28(2):339-344. PubMed ID: 28485997
[TBL] [Abstract][Full Text] [Related]
13. Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis
Roddy E; Mallen CD;
Ann Rheum Dis; 2021 Dec; 80(12):e203. PubMed ID: 31801739
[No Abstract] [Full Text] [Related]
14. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
George M; Pullman-Mooar S; Hussain F; Schumacher HR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
[TBL] [Abstract][Full Text] [Related]
15. Postoperative Recurrent Gout Flares: A Cross-sectional Study From China.
Zhuo Y; Cai X; Hou Z; Zhu Z; Cai D
J Clin Rheumatol; 2020 Aug; 26(5):197-203. PubMed ID: 31483351
[TBL] [Abstract][Full Text] [Related]
16. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey.
Rider LG; Parks CG; Wilkerson J; Schiffenbauer AI; Kwok RK; Noroozi Farhadi P; Nazir S; Ritter R; Sirotich E; Kennedy K; Larche MJ; Levine M; Sattui SE; Liew JW; Harrison CO; Moni TT; Miller AK; Putman M; Hausmann J; Simard JF; Sparks JA; Miller FW;
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI143-SI150. PubMed ID: 35460240
[TBL] [Abstract][Full Text] [Related]
17. Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.
Roddy E; Clarkson K; Blagojevic-Bucknall M; Mehta R; Oppong R; Avery A; Hay EM; Heneghan C; Hartshorne L; Hooper J; Hughes G; Jowett S; Lewis M; Little P; McCartney K; Mahtani KR; Nunan D; Santer M; Williams S; Mallen CD
Ann Rheum Dis; 2020 Feb; 79(2):276-284. PubMed ID: 31666237
[TBL] [Abstract][Full Text] [Related]
18. Managing your patient with gout: a review of treatment options.
Doghramji PP
Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
[TBL] [Abstract][Full Text] [Related]
19. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
Kuritzky L; Panchal R
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
Peterson DM
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
